Document is current
Any future updates will be listed below
-
Authors
Channapragada, Theja
Stine, Jonathan G.
- License Information
-
More Information
Article History
Received: 7 April 2025
Accepted: 12 May 2025
First Online: 31 May 2025
Declarations
:
: Dr. Stine receives or has received research support from Astra Zeneca, Galectin, Kowa Inc, Novo Nordisk, Regeneron and Zydus Therapeutics. Dr. Stine consults Novo Nordisk and is on an Advisory Board for Madrigal. All other authors have no relevant conflicts of interest to report.
: AI-based software was used for grammatical and stylistic editing at various parts of this manuscript.
Free to read: This content has been made available to all.
